Chorda Pharma, Inc. announced it raised $293,000 in an amended filing from an offering of $500,000

Company

Location

About

Chorda Pharma was founded to address the growing incidence of arthritis, diabetic neuropathy, sports injuries, and other ailments requiring long-term treatment to relieve pain. We are developing a pipeline of proprietary analgesics for managing chronic pain. Our medications are opioid-free, and offer safe and effective pain relief to millions of patients. Chorda's first drug is Capsadyn™, which is an over-the-counter (OTC) topical cream that is now available.